.RESEARCH STUDY FEATURE.06 August 2024.
A large randomized measured test along with cisgender females highlights the difficulties of faithfulness to a day-to-day oral preexposure prevention regiment and also demonstrates that twice-yearly treatment of lenacapavir can preserve successful HIV protection amounts over 6 months.